Amarin Corp Plc (AMRN)

[onecardchuck]

Below is the excerpt from the call transcript about C19. So short term?

"People with cardiovascular risk factors appear to be at greater risk for COVID-19. We, together with leading physicians on multiple continents of the world, are reviewing whether there are opportunities for VASCEPA to be used in acute or chronic settings to potentially mitigate heightened cardiovascular risks associated with COVID-19. Whether or not such efforts will succeed are not yet known, nor do we yet know the extent of such potential investigation. However, we feel it is incumbent to try to help. Currently, such work is being evaluated based upon what is already known about VASCEPA, which is that it lowers cardiovascular risk in high-risk patients. If new data or other information presents itself regarding potential benefits of using VASCEPA in COVID-19 patients, we, and/or our medical collaborators, will make this known."